Penserra Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Penserra Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-990	Closed	-$37K	–	1438
2021 Q1	$37K	Sell	990 -75	-7%	-$1.87K	﹤0.01%	871
2020 Q4	$18K	Buy	+1,065	New	+$13.3K	﹤0.01%	865

Penserra Capital Management's FPRX Position: Q2 2021 in Review

Penserra Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 990 shares — an estimated $37K sold.

Penserra Capital Management first reported a position in FPRX in Q4 2020 and held it in 2 quarters. The position peaked at $37K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Penserra Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Penserra Capital Management sold 990 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $37K.
Penserra Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
Penserra Capital Management's Five Prime Therapeutics, Inc. position peaked at $37K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.